Forte Biosciences, Inc. (FBRX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol FBRX
- Company Forte Biosciences, Inc.
- Price $48.86
- Changes Percentage 8.6
- Change 3.87
- Day Low $42
- Day High $50
- Year High $35.8
- Year Low $9.1
- Market Cap $236,056,900
- Price Avg 50 EMA (D) $26.2
- Price Avg 200 EMA (D) $21.98
- Exchange NASDAQ
- Volume 321,827
- Average Volume 287,274
- Open $42.59
- Previous Close $44.99
- EPS -4.58
- PE -3.71
- Earnings Announcement 2026-08-13 04:00:00
- Shares Outstanding $13,885,700
Company brief: FORTE BIOSCIENCES, INC. (FBRX )
- Healthcare
- Biotechnology
- Dr. Paul A. Wagner Ph.D.
- https://www.fortebiorx.com
- US
- N/A
- 04-13-2017
- US34962G1094
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.